Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
Clinical trial NCT06821048 · RECRUITING
Trial details
- NCT number
- NCT06821048
- Sponsor
- Weijia Fang, MD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2026-06-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.